Grail (NASDAQ:GRAL) Trading Down 3.7% - Should You Sell?

Grail, Inc. (NASDAQ:GRAL - Get Free Report)'s share price traded down 3.7% during trading on Friday . The company traded as low as $37.64 and last traded at $38.01. 1,063,475 shares traded hands during mid-day trading, a decline of 16% from the average session volume of 1,259,728 shares. The stock had previously closed at $39.49.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on GRAL shares. Morgan Stanley boosted their price objective on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th. Canaccord Genuity Group upped their price target on Grail from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th.

Grail Price Performance

The company has a market cap of $1.36 billion and a P/E ratio of -0.62. The company has a 50 day moving average of $32.98 and a 200-day moving average of $28.97.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, beating the consensus estimate of ($4.03) by $0.93. The business had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. Research analysts anticipate that Grail, Inc. will post -15.15 EPS for the current year.

Insider Buying and Selling at Grail

In related news, CFO Aaron Freidin sold 41,150 shares of the stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $1,396,219.50. Following the transaction, the chief financial officer now owns 294,020 shares of the company's stock, valued at $9,976,098.60. This represents a 12.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Robert P. Ragusa sold 94,035 shares of the firm's stock in a transaction dated Friday, May 2nd. The shares were sold at an average price of $33.93, for a total value of $3,190,607.55. Following the sale, the chief executive officer now owns 734,627 shares in the company, valued at $24,925,894.11. The trade was a 11.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 183,398 shares of company stock worth $6,222,694 over the last three months. 1.85% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of GRAL. Lindbrook Capital LLC bought a new stake in shares of Grail in the 4th quarter worth approximately $28,000. State of Tennessee Department of Treasury purchased a new position in Grail in the 4th quarter worth $28,000. Caldwell Sutter Capital Inc. bought a new stake in Grail in the first quarter worth $28,000. Sterling Capital Management LLC purchased a new position in shares of Grail in the fourth quarter worth about $29,000. Finally, Wellington Shields Capital Management LLC purchased a new position in shares of Grail in the fourth quarter worth about $33,000.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.